The company’s lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn’s disease. Receive News & Ratings ...

Kamala Harris told her friends she felt sad as Joe Biden said he could have won the election. But despite all this, Kamala Harris never spoke against Joe Biden and did not blame him for the ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

“We are excited to move from the SAD to the MAD portion of our Phase 1a/b study of PALI-2108, a significant milestone that brings us one-step closer to delivering an innovative, safe, and ...

Carlsbad, CA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage ...

Kamala Harris has told friends that she is deeply sad about President Joe Biden’s claim that he could have won the 2024 election. Biden said in an interview at the start of January that he thought he ...

The company’s lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn’s disease.

“I was sad. Of course the president is entitled, and he should give a farewell speech. There is no question about that. But different times invade us all, and when you see the times that we live ...

In addition to the NLRP3 inhibitors, Ventyx has provided updates on its inflammatory bowel disease portfolio, including tamuzimod (VTX002) and VTX958, both of which have completed Phase 2 clinical ...